Long QT Syndrome News and Research

RSS
Long QT syndrome (LQTS) is a disease that affects the normal heart rhythm and electrical activity. It may lead to sudden onset and dangerous arrhythmias (irregularities of heart rate and rhythm) which may be brought on by triggers like exercise or stress.
ASCO 2015: Novartis presents data on Zykadia and Tafinlar studies for non-small cell lung cancer

ASCO 2015: Novartis presents data on Zykadia and Tafinlar studies for non-small cell lung cancer

Lenvatinib-everolimus combination extends PFS in patients with mRCC versus everolimus alone

Lenvatinib-everolimus combination extends PFS in patients with mRCC versus everolimus alone

Eisai Phase 3 trial of eribulin meets primary endpoint in patients with advanced soft tissue sarcoma

Eisai Phase 3 trial of eribulin meets primary endpoint in patients with advanced soft tissue sarcoma

Jianmin Cui receives $1.7 million NIH grant to study heart's inner mechanisms

Jianmin Cui receives $1.7 million NIH grant to study heart's inner mechanisms

Eisai announces FDA approval of LENVIMA (lenvatinib) for treatment of RAI-refractory DTC

Eisai announces FDA approval of LENVIMA (lenvatinib) for treatment of RAI-refractory DTC

Janssen announces submission of NDA for three-month paliperidone palmitate

Janssen announces submission of NDA for three-month paliperidone palmitate

Johns Hopkins researchers capture images of protein complex that keeps hearts beating

Johns Hopkins researchers capture images of protein complex that keeps hearts beating

QT Medical partners with LA BioMed to identify infants at risk of long QT syndrome

QT Medical partners with LA BioMed to identify infants at risk of long QT syndrome

Study suggests that energy drinks can cause heart problems

Study suggests that energy drinks can cause heart problems

Phase 3 trial: NEXAVAR tablets fail to meet primary endpoint in HER2-negative breast cancer patients

Phase 3 trial: NEXAVAR tablets fail to meet primary endpoint in HER2-negative breast cancer patients

FDA grants Breakthrough Therapy status to Novartis' CTL019 for treatment of relapsed/refractory ALL

FDA grants Breakthrough Therapy status to Novartis' CTL019 for treatment of relapsed/refractory ALL

Scientists discover 23 new genes linked to heart rhythm

Scientists discover 23 new genes linked to heart rhythm

Genetic variant linked to sudden cardiac death leads to protein overproduction in heart cells

Genetic variant linked to sudden cardiac death leads to protein overproduction in heart cells

Bayer and Onyx announce Phase 3 trial evaluating use of NEXAVAR for patients with HCC after local ablation

Bayer and Onyx announce Phase 3 trial evaluating use of NEXAVAR for patients with HCC after local ablation

Copenhagen scientists study link between congenital arrhythmia and hypoglycemia

Copenhagen scientists study link between congenital arrhythmia and hypoglycemia

NEXAVAR tablets receive FDA approval for treatment of patients with thyroid cancer

NEXAVAR tablets receive FDA approval for treatment of patients with thyroid cancer

CDC and NIH collaborate to create Sudden Death in Young Registry

CDC and NIH collaborate to create Sudden Death in Young Registry

NHCS researchers discover potential cure for long QT syndrome 2

NHCS researchers discover potential cure for long QT syndrome 2

FDA grants Priority Review designation to sNDA for Nexavar tablets

FDA grants Priority Review designation to sNDA for Nexavar tablets

Bayer, Onyx submit sNDA to FDA, marketing authorization application to EMA for Nexavar tablets

Bayer, Onyx submit sNDA to FDA, marketing authorization application to EMA for Nexavar tablets